Clinical Efficacy Observation on Dysmenorrhea of Cold-damp Stagnation Type with Graphene Thermotherapy Based on the Idea of TCM "Preventive Treatment of Disease"

[Objectives] To explore the clinical efficacy of graphene waist protector on dysmenorrhea of cold-damp stagnation type.[Methods]150 patients with cold-damp stagnation type were randomly divided into 3 groups: 50 cases in the experimental group( using graphene waist protector),49 cases in the blank group( using the waist protector for removing the heating plate) and 51 cases in the control group( taking the Tongjingbao granules). After intervening for 3 menstrual cycles,visual analogue scale and the COX menstrual symptom scale were used to evaluate the clinical efficacy of graphene waist protector. [Results] The clinical effective rate of dysmenorrhea in experimental group was 64. 00%,while that of control group was 72. 54%. With the effective rate of symptoms,the test group was 56. 00% and the control group was 64. 70%; VAS dysmenorrhea visual score,duration of dysmenorrhea,severity of COX dysmenorrhea and duration of symptoms after intervention were significantly decreased in both experimental group and control group,the differences were statistically significant( P < 0. 05); for the differences of the scores before and after the intervention: the differences of the experimental group and the control group were statistically significant( P < 0. 05) compared with those of the blank group. There was no significant difference between experimental group and control group( P > 0. 05). [Conclusions] Graphene belt of experimental group and Tongjingbao granules of control group both have therapeutic effects on dysmenorrhea of cold-damp stagnation type. Graphene waist protector can relieve the pain and its accompanying symptoms in patients with primary dysmenorrhea of cold-damp stagnation type.

Analysis of the Curative Effect of Cold-Dampness Epidemic Prescription(寒湿疫方)on the Main Symptoms of Quarantined People in Community

Objective:To evaluate the curative effect of"Cold-Dampness Epidemic Prescription(寒湿疫方)"on the main symptoms of quarantined people in community based on real-world research data,and to provide scientific basis for Chinese medicine to fight Coronavirus disease 2019 under the"Wuchang Model".Methods:From February 4,2020 to March 5,2020,the data of community quarantined people who only took"Cold-Dampness Epidemic Prescription(寒湿疫方)"under the management of"Wuchang Model"were collected,and the demographic characteristics,basic diseases,distribution of sick people,treatment process,disappearance time of eight clinical symptoms,adverse reactions and clinical outcomes of patients were statistically analyzed.Results:A total of 951 quarantined people in COVID-19 community were included,including 440 males(46.27%)and 511 females(53.73%),the oldest was 89 years old,the youngest was 2 years old,and the average age was 43.34 years old;Among the quarantined population in the community,there were 141 cases diagnosed by CDC(14.83%),CDC excluded 810 cases(85.17%);106 cases of CDC were diagnosed as COVID-19,accounting for 47.96%of the self-reported cases,and 311 cases(32.70%)had previous medical history;696(73.19%)had no obvious symptoms,and 255(26.81%)developed fever,fatigue,cough,sputum,shortness of breath,loss of appetite,diarrhea and mood,of which 187(19.66%)had cough symptoms,followed by sputum coughing(14.30%)and fever(13.56%).Conclusion:"Cold-Dampness Epidemic Prescription(寒湿疫方)"is effective in treating the clinical symptoms of COVID-19 without obvious adverse reactions.

Discuss ion on the Correlation Between Yang Deficiency&Cold-dampness and Malignant Tumors Based on"Diseases producing the liquid that is clear and chill all result from coldness"

Tumor is defined as a kind of chronic diseases by the World Health Organization.The integrative traditional Chinese and western medicine works well on the treatment of tumors,even in advanced patients or patients with recurring and metastatic tumor.However,the pathogenic mechanism of tumors is still unclear.Therefore,based on the 19 th pathogenesis in Yellow Emperor's Internal Class that"Diseases producing the liquid that is clear and chill all result from coldness",the paper explore s the etiology pathogenesis of malignant tumors,and the correlation between which and tumor recurrence and metastasis,and also discusses the rules for the treatment of tumors at various stages with great method of warming yang for dispelling cold.

Efficacy of TCM Fumigation Using Dampness-and-cold-dispelling Formula Combined with Methotrexate and Leflunomide Treating Rheumatoid Arthritis with Cold-dampness Bi Syndrome

Background:Rheumatoid arthritis(RA),a chronic autoimmune disease,has a high incidence and disability rate,causing patients significant discomfort.Although several medicines can be effective,they are also associated with significant adverse effects.In contrast,fumigation as one of the most often used traditional Chinese medicine(TCM)external therapy has shown both efficacy and safety with less side effect.In light of this,we comple-ment western medicine treatment with TCM fumigation therapy to improve patients’clinical efficacy,alleviate symptoms,and improve prognosis.Objective:To investigate the therapeutic effect of TCM fumigation and modern medicine combined therapy in treating RA patients with cold-dampness Bi syndrome.Methods:A single-center,randomized,controlled study was designed.From January 2022 to December 2022,a total of 60 RA patients with cold-dampness Bi syndrome were enrolled in the study.The control group(30 cases)received conventional modern medicine treatment with methotrexate for 4 weeks,while the observation group(30 cases)for 4 weeks received a combination of TCM fumigation treatment and conventional modern medicine.The effects of the two groups were comprehensively compared,including the changes in TCM symptom scores and laboratory indicators,as well as the use of visual analogue scale(VAS)and health status rating scale(HAQ)before and after treatment.Results:The total effective rate of the observation group was 93.3%,which was significantly higher than that of the control group,which is 70%(P<0.05).Before treatment,there were no significant differences in joint functional activity,pain visual analogue scale(VAS),health assessment questionnaire(HAQ-DI)and laboratory indexes between the two groups(P>0.05).After treatment,each group compared to their initial condition,respectively,showed major improvement of joint functional activity and significantly decreased VAS,HAQ-DI,and RA-related biomarkers(P<0.05);inter-group comparison of these indicators showed significanty further enhanced effect of TCM fumigation combined therapy on the RA-related biomarkers and joint functional activity of patients(P<0.05),yet the control group receiving only modern medicine showed better results of the VAS and HAQ-DI.Conclusion:The TCM fumigation combined therapy is effective to treat RA patients with cold-dampness Bi syn-drome,and to enhance their life quality,improving the joint function,and reducing inflammation.

Efficacy observation on long snake moxibustion for lumbar disc herniation with cold-dampness syndrome

Objective:To observe and compare the clinical efficacy difference among long snake moxibustion,acupuncture and western medication for treating lumbar disc herniation with cold-dampness syndrome,and to provide a preferred treatment for cold-dampness lumbar disc herniation.Methods:A total of 90 patients with cold-dampness lumbar disc herniation were randomized into three groups according to the random number table,including the long snake moxibustion group(31 cases),the acupuncture group(28 cases)and the western medication group(31 cases).Treated with long snake moxibustion,patients in the long snake moxibustion group.The acupuncture group was treated with conventional acupuncture therapy,by adopting acupoints of Shènshū(肾俞 BL23),Dàchángshū(大肠俞BL25),Yāoyángguān(腰阳关GV3),Wěizhōng(委中 BL40)and local Ashi points.Patients in the western medication group were given oral diclofenac sodium.Visual analogous scale(VAS),Oswestry Dysfunction Index(ODI)score,yang deficiency scale score and clinical efficacy were observed before and after treatment.Results:(1)The VAS scores of the patients after treatment in each group decreased compared with those before the treatment.The long snake moxibustion group decreased from 7.22±1.14 to 1.10±0.75(P<0.05);the acupuncture group,from 6.75±1.18 to 1.46±0.88(P<0.05);and the western medication group,from 7.38±1.02 to 1.51 ±0.81(P<0.05).After treatment,the VAS score of the long snake moxibustion group was lower than that of the acupuncture and western medication groups,the differences were statistically significant(both P<0.05).(2)ODI scores of all the groups were lower than those before the treatment.The long snake moxibustion group decreased from 33.35±10.85 to 7.84±3.59(P<0.05);the acupuncture group,from 31.65±8.23 to 9.00±6.10(P<0.05);and the western medication group from 27.77±7.30 to 23.87±10.81(P<0.05).The score of ODI in the long snake moxibustion group was lower than those in the acupuncture and western medication groups,the differences were statistically significant(both P<0.05).(3)The scores of yang deficiency scale score in each group were lower than those before treatment.The long snake moxibustion group decreased from 61.81±15.49 to 32.26±6.08(P<0.05);the acupuncture group,from 67.64±12.47 to 62.00±17.77(P<0.05);and the western medication group from 64.68 ± 12.73 to 59.77±14.02(P<0.05).The score of yang deficiency scale of the long snake moxibustion group was lower than those of the acupuncture and western medication groups after treatment,the differences were statistically significant(both P<0.05).(4)The effective rates of the long snake moxibustion group,acupuncture group and western medication group were 93.55%,85.71% and74.19% respectively,and the differences among three groups were statistically significant(all P<0.05).Conclusion:The long snake moxibustion therapy has a significant clinical effect for lumbar disc herniation with cold-damp syndrome,which is better than those of acupuncture and western medication groups,the therapy can effectively improve the patients' physical constitution as a preferred solution for cold-damp lumbar disc herniation by acupuncture therapy.

寒湿阻滞型腰痛大鼠模型构建及独活寄生汤干预效果的实验研究

目的构建大鼠寒湿阻滞型腰痛动物模型,评估独活寄生汤对该模型的干预效果。方法24只雄性SD大鼠适应性喂养7 d后,随机分为空白组、模型组和独活寄生汤组。空白组仅腹腔注射戊巴比妥钠麻醉,模型组、独活寄生汤组在腹腔注射戊巴比妥钠麻醉下行“腰椎后柱结构部分切除术”,并在寒湿环境下饲养6周。造模2周后,空白组、模型组予等体积蒸馏水灌胃,独活寄生汤组予独活寄生汤18.6 g/(kg·d)灌胃,均连续灌胃4周。比较各组大鼠一般情况、自发性疼痛行为学评分和神经功能评分,CT三维成像评估脊柱生理曲度形态改变情况,椎间盘组织病理切片评估椎间盘髓核病变程度。结果造模后1周,与空白组比较,模型组、独活寄生汤组开始出现少动、皮毛无光泽、嗜睡蜷缩、反应迟钝、大便稀溏表现,体质量减轻(P<0.05),自发性疼痛行为学评分和神经功能评分升高(P<0.05);给药后3周,与模型组比较,独活寄生汤组疼痛行为学评分和神经功能评分降低(P<0.05)。给药后4周,与模型组比较,独活寄生汤组大鼠脊柱CT三维成像形态退变不明显,椎间盘组织病理切片显示,独活寄生汤组椎间盘髓核病变不明显。结论“腰椎后柱结构部分切除术+寒湿环境饲养”可成功构建SD大鼠寒湿阻滞型腰痛动物模型,独活寄生汤对该模型有较好的干预效果。

参蝎止痛胶囊联合董氏奇穴对寒湿痹阻型膝骨关节炎患者的临床疗效

目的 探讨参蝎止痛胶囊联合董氏奇穴对寒湿痹阻型膝骨关节炎患者的临床疗效。方法 80例患者随机分为对照组和观察组,每组40例,对照组给予董氏奇穴,观察组在对照组基础上加用参蝎止痛胶囊,疗程1个月。检测临床疗效、中医证候评分、LKSS评分、WOMAC评分、NRS评分、AIMS2-SF评分、sIL-4R、TNF-α、HMGBl、TLR-4、BALP、BGP、β-CTX变化。结果 观察组总有效率高于对照组(P<0.05)。治疗后,2组中医证候评分、WOMAC评分、NRS评分、sIL-4R、TNF-α、HMGBl、TLR-4、β-CTX降低(P<0.05),LKSS评分、AIMS2-SF评分、BALP、BGP升高(P<0.05),以观察组更明显(P<0.05)。结论 参蝎止痛胶囊联合董氏奇穴可抑制寒湿痹阻型膝骨关节炎患者机体炎症反应,改善骨代谢,缓解膝关节疼痛及临床症状。

益元宣肺汤对25例新冠肺炎CT值的影响

目的分析深圳地区2022年新型冠状病毒肺炎患者的舌象、症状及用药史,多辨为三焦壅滞、肺脾肾虚,拟益元宣肺汤,观察其对CT值恢复的临床疗效。方法选取25例符合益元宣肺汤证型者进行治疗观察,选同期对照组25例,观察益元宣肺汤对CT值的影响。结果治疗前对照组的N基因(31.99±1.16)、O基因(33.49±1.94)与治疗组的N基因(31.45±2.85)、O基因(33.40±3.96)比较,差异无统计学意义(P>0.05);对照组治疗到CT值符合出院标准所需时间为(4.28±1.88)d,治疗组为(2.80±1.26)d,差异有统计学意义(P<0.05)。结论治疗组通过服用益元宣肺汤,CT值恢复明显比对照组快,表明以调动肺脾肾之气、疏通三焦气机为主的益元宣肺汤效果明显。扶正补肺脾肾、通宣三焦的治疗方法,在促进病情好转,加快人体清除病毒的速度方面作用明显,利于新型冠状病毒肺炎患者康复。

关节克痹丸联合关节镜微创术治疗寒湿痹阻型膝骨关节炎临床研究

目的:观察关节克痹丸联合关节镜微创术治疗寒湿痹阻型膝骨关节炎的临床疗效。方法:选取2021年9月—2023年7月在南阳市中心医院骨科接受治疗的128例寒湿痹阻型膝骨关节炎患者作为研究对象,采用随机数字表法将患者分为观察组、对照组各64例。2组均给予关节镜微创术治疗,对照组术后给予甲氨蝶呤片治疗,观察组术后给予关节克痹丸治疗。比较2组临床疗效及治疗前后美国特种外科医院膝关节评分系统(HSS)、世界卫生组织生存质量测定量表简表(WHOQOL-BREF)、中医证候评分、微循环功能指标[血细胞平均运动速度(AVBC)、运动血细胞浓度(CMBC)、微血管血流灌注量(MBP)、经皮氧分压(Tcp O2)]、血清炎症因子[白细胞介素-6 (IL-6)、C-反应蛋白(CRP)]水平。结果:治疗后,观察组总有效率90.62%,对照组总有效率75.00%,2组比较,差异有统计学意义(P<0.05)。2组治疗后HSS、WHOQOL-BREF评分及AVBC、CMBC、MBP、Tcp O2均较治疗前升高(P<0.05),且观察组治疗后HSS、WHOQOL-BREF评分及微循环功能指标高于对照组(P<0.05)。2组治疗后中医证候评分及血清IL-6、CRP水平均较治疗前降低(P<0.05),且观察组治疗后中医证候评分及血清炎症因子水平均低于对照组(P<0.05)。结论:关节克痹丸联合关节镜微创术治疗寒湿痹阻型膝骨关节炎疗效确切,能够改善患者关节功能及微循环,减轻炎症反应。

辛丑年运气方治疗皮肌炎相关间质性肺疾病所致难治性咳嗽

基于五运六气理论,从整体恒动的观念出发,分析辛丑年运用五味子汤合备化汤治疗皮肌炎相关间质性肺疾病(DM-ILD)所致难治性咳嗽的疗效。辛丑全年,岁水不及,太阴湿土司天,太阳寒水在泉,整年气化以寒湿为主。寒湿为阴邪,易伤阳气,尤伤肾阳,故辛丑年防治疾病应注重扶阳温中。五味子汤和备化汤是陈无择根据辛丑年运气特点所创的运气方,二者配伍具有温肾健脾散寒、温肺化痰滋阴之效,恰合辛丑年DMILD所致难治性咳嗽的病机特点,故辛丑年以其治疗该病具有良好疗效。

隔姜灸联合定向透药治疗重症卒中泄泻寒湿证临床观察

目的探究隔姜灸联合中医定向透药治疗重症卒中患者肠内营养泄泻寒湿证的临床疗效。方法选取2022年1月—2022年12月收治的重症卒中行肠内营养的泄泻寒湿证患者96例。按随机数字表法分成观察组(48例,神阙隔姜灸联合中医定向透药)和对照组(48例,常规腹泻护理联合药物治疗)。比较2组患者治疗总体疗效。结果观察组临床疗效优于对照组(P<0.05)。治疗7 d后,观察组大便性状积分明显低于对照组(P<0.05)。结论隔姜灸联合中医定向透药治疗应用于重症卒中患者肠内营养泄泻寒湿证疗效确切,可在临床推广。

腕踝针联合药物罐治疗寒湿痹阻型肩周炎临床观察

目的观察腕踝针联合药物罐治疗寒湿痹阻型肩周炎的临床效果。方法将80例寒湿痹阻型肩周炎患者随机分为A组、B组、C组和D组,每组20例。A组采用口服双氯芬酸钠缓释片治疗,B组、C组和D组在A组基础上分别采用腕踝针、药物罐及腕踝针联合药物罐治疗。观察各组治疗前后视觉模拟量表(VAS)评分、肩关节功能Mallet评分的变化情况,以及各组临床效果。结果各组治疗后1 d、7 d、14 d、21 d的VAS及肩关节功能Mallet评分与治疗前比较,差异均有统计学意义(P<0.05);治疗后1 d、7 d、14 d、21 d,B组、C组和D组VAS及肩关节功能Mallet评分与A组比较,差异均有统计学意义(P<0.05),D组VAS及Mallet评分与B组和C组比较,差异均有统计学意义(P<0.05)。结论腕踝针联合药物罐治疗寒湿痹阻型肩周炎效果确切,能有效改善患者肩关节疼痛及活动受限的症状。

耳穴压豆联合隔物灸治疗寒湿凝滞型原发性痛经效果分析

目的探讨寒湿凝滞型原发性痛经患者行耳穴压豆+隔物灸治疗的效果。方法选取94例寒湿凝滞型原发性痛经患者为研究对象,按照随机数表法分为对照组和研究组,每组47例。对照组实施常规对症治疗,研究组在对照组基础上给予耳穴压豆+隔物灸治疗,比较两组临床疗效、中医证候积分、疼痛程度、疼痛持续时间、痛经症状程度。结果治疗后研究组视觉模拟评分法(VAS)评分低于对照组,疼痛持续时间短于对照组(P<0.05);治疗后研究组COX痛经症状量表(CMSS)评分低于对照组(P<0.05);治疗后研究组中医证候积分低于对照组(P<0.05);研究组总有效率为93.62%,高于对照组的74.47%(P<0.05)。结论寒湿凝滞型原发性痛经采用耳穴压豆联合隔物灸治疗效果较好,可减轻中医证候,快速消除症状,减轻患者痛感,并加快患者康复,值得临床推广与应用。

红外热像技术辅助下探讨中药薰药治疗风寒湿痹型膝骨关节炎的临床研究

目的:观察中药熏药治疗风寒湿痹型膝骨关节炎(Knee Osteoarthritis,KOA)患者的临床疗效,并采用医用红外热成像仪进行疗效系统评价。方法:根据随机数字表法将60例风寒湿痹型KOA患者分为治疗组与对照组,对照组予口服艾瑞昔布片,治疗组在对照组治疗的基础上配合柳州市中医医院中药验方进行膝部中药熏药治疗。治疗8周后,比较两组治疗前后膝周疼痛视觉模拟评分法(Visual Analogue Scale,VAS)评分、西安大略和麦克马斯特大学骨关节炎指数量表(Western Ontario and McMaster Universities Osteoarthritis Index,WOMAC)评分、超敏C反应蛋白、红细胞沉降率、经络穴位皮温等的变化情况。结果:治疗组与对照组VAS评分和WOMAC评分及炎症因子水平较治疗前均显著降低(P<0.01),治疗组VAS评分和WOMAC评分及炎症因子水平均低于对照组(P<0.01);两组治疗后主要穴位均温显著高于治疗前(P<0.01),且治疗组较对照组的均温改善显著(P<0.01);治疗组愈显率显著高于对照组,两组患者的愈显率进行比较,P<0.05。结论:中药验方熏药治疗方案能改善风寒湿痹型KOA患者的证候和有效缓解疼痛,显著降低KOA评分和提高相应经络穴位的红外皮温,并通过红外热像技术得到证实,可为临床适宜技术推广与应用提供可靠的临床数据和值得借鉴的研究思路。

基于16S rDNA测序技术的膝骨关节炎湿热痹阻证、寒湿痹阻证患者肠道菌群差异性研究

目的比较膝骨关节炎(KOA)湿热痹阻证、寒湿痹阻证患者与健康人群肠道菌群构成及多样性特征的差异,探讨2种中医证型KOA患者的肠道菌群特征。方法根据纳入及排除标准,选取湿热痹阻证组、寒湿痹阻证组、健康对照组各10例,收集粪便标本,利用16S rDNA测序技术,通过Alpha及Beta多样性分析等方法,对比组间肠道菌群差异。结果3组肠道菌群的物种丰富度无明显差异,但寒湿痹阻证组与湿热痹阻证组、健康对照组之间物种多样性差异有统计学意义(P<0.05)。3组肠道菌群构成差异有统计学意义(P=0.001)。门水平上拟杆菌门和厚壁菌门占明显优势,属水平上湿热痹阻证组和寒湿痹阻证组普雷沃氏菌属丰度增加。湿热痹阻证组肠杆菌科、毛螺菌属、克雷伯氏菌属等丰度较大,寒湿痹阻证组普雷沃氏菌属、假单胞菌属等丰度较大。结论KOA湿热痹阻证与寒湿痹阻证患者肠道菌群结构存在一定差异。

石氏温经强腰方结合中药熏蒸治疗腰椎间盘突出症(寒湿痹阻型)临床效果研究

目的观察石氏温经强腰方结合中药熏蒸治疗腰椎间盘突出症(寒湿痹阻型)临床效果。方法将该院近1年收治的81例腰椎间盘突出症(寒湿痹阻型)患者纳入研究,根据治疗方法不同将其以随机数字表法分为对照组(40例)与中医组(41例),对照组患者采取西医常规疗法治疗,中医组患者在对照组患者治疗基础上结合石氏温经强腰方以及中药熏蒸治疗。比较临床治疗效果、治疗前后中医证候积分(腰腿冷痛着重、痛连臀腿、肢体发凉、舌质淡胖等)变化、C反应蛋白(C-reactive protein,CRP)以及肿瘤坏死因子α(tumor necrosis factor-α,TNF-α)等炎症因子水平变化、疼痛量表[视觉模拟疼痛评分法(visual analogue scale,VAS)]评分变化、日本骨科协会评估治疗分数(Japanese Orthopaedic Associationscores,JOA评分)变化、不良反应。结果中医组患者治疗总有效率(95.12%,39/41)比对照组患者(80.00%,32/40)更高(P<0.05);治疗前,两组患者中医证候积分(腰腿冷痛着重、痛连臀腿、肢体发凉、舌质淡胖等)、CRP及TNF-α水平、VAS评分以及JOA评分等指标比较,差异无统计学意义(P>0.05),经治疗后两组患者中医证候积分(腰腿冷痛着重、痛连臀腿、肢体发凉、舌质淡胖等)、CRP及TNF-α水平、VAS评分均显著下降,中医组低于对照组,JOA评分均上升,中医组高于对照组(均P<0.05);对照组患者出现1例恶心,1例呕吐,中医组未见不良反应(P>0.05)。结论石氏温经强腰方结合中药熏蒸治疗腰椎间盘突出症(寒湿痹阻型)临床效果显著,患者症状好转,疼痛减轻,腰椎功能恢复好,且未见不良反应,安全可靠。

基于代谢组学研究经典名方达原饮对RSV寒湿郁肺证小鼠模型的作用机制

目的 基于超高液相色谱-四极杆静电场轨道阱质谱法(ultra-high performance liquid chromatography-quadrupole electrostatic field orbital trap mass spectrometry, UHPLC-QE-MS)研究达原饮对模型小鼠的干预及肺组织代谢物的影响,以探究达原饮治疗呼吸道合胞病毒(Respiratory syncytial virus, RSV)寒湿郁肺证的作用机制。方法 采用寒湿刺激加RSV滴鼻感染的方法建立RSV寒湿郁肺证小鼠模型,综合小鼠活动状态、肺指数和肺组织病理,结合肺组织中白介素-6(Interleukin-6,IL-6)和白介素-1β(Interleukin-1β,IL-1β)炎症因子的含量,初步评价达原饮对RSV寒湿郁肺证小鼠的治疗效果。利用UHPLC-QE-MS技术检测正常组、模型组、达原饮中剂量组小鼠肺组织代谢物,以正交偏最小二判别分析进行多元统计分析模式识别,以P<0.05且VIP值>1为条件筛选差异代谢物,并借助MetaboAnalyst 5.0数据库富集代谢通路。结果 达原饮可以显著改善RSV寒湿郁肺证小鼠的一般状态,降低肺指数,改善肺组织病理,并降低肺组织中IL-6、IL-1β的含量。代谢组学结果显示,与达原饮调控相关的差异代谢物共有35个,主要涉及嘌呤代谢、花生四烯酸、甘氨酸、丝氨酸和苏氨酸代谢等代谢通路。结论 从代谢组学角度分析了达原饮治疗RSV寒湿郁肺证的作用机制,为达原饮抗病毒研究及临床应用奠定了基础。

隔药灸联合中医五行手指操治疗寒湿痹阻型类风湿关节炎的疗效观察

目的探讨隔药灸联合中医五行手指操改善寒湿痹阻型类风湿关节炎(rheumatoid arthritis,RA)的临床疗效。方法将90例寒湿痹阻型RA患者随机分为对照组和观察组,每组45例。对照组予以来氟米特片、艾拉莫德片、塞来昔布胶囊口服;观察组在对照组基础上行隔药灸联合中医五行手指操,其中隔药灸选取脾俞、阳陵泉、腰阳关、命门及手阳明大肠经、手少阳三焦经、手太阳小肠经上的阿是穴,每日1次,每次30 min。两组均治疗10 d。分别于治疗前后观察两组患者的疼痛视觉模拟评分(visual analogue scale,VAS)、炎症指标红细胞沉降率(erythrocyte sedimentation rate,ESR)、C反应蛋白(C-reactive protein,CRP)、焦虑自评量表(self-rating anxiety scale,SAS)、健康评估问卷(health assessment questionnaire,HAQ)、中医证候积分,并于治疗后评定两组患者的临床疗效。结果治疗后,两组患者的VAS、ESR、CRP、SAS、HAQ及中医证候积分均较治疗前降低(P<0.05,P<0.01),且观察组上述指标均低于对照组(P<0.05,P<0.01)。观察组总有效率为80.00%,高于对照组的55.56%(P<0.01)。结论隔药灸联合中医五行手指操能改善寒湿痹阻型RA患者临床症状,提高患者生存质量。

甘草附子汤对风寒湿痹型痛风性关节炎小鼠的治疗作用及机制

目的探讨甘草附子汤(Licorice aconite decoction,LA)对风寒湿痹型痛风性关节炎小鼠的治疗作用及机制。方法将40只ICR小鼠随机分为空白组(CON)、模型组(MOD)、非布司他组(Febuxostat,FBX,8 mg/(kg·d))和甘草附子汤组(LA,6.4 g/(kg·d))。同时建立风寒湿痹型痛风性关节炎小鼠模型,持续2周。观察小鼠关节肿胀情况;检测小鼠血清尿酸(uric acid,UA)、丙二醛(malondialdehyde,MDA)、过氧化氢酶(catalase,CAT)、超氧化物歧化酶(superoxide dismutase,SOD)水平;检测肝脏中黄嘌呤氧化酶(Xanthine oxidase,XOD)水平;采用ELISA试剂盒检测血清肿瘤坏死因子-α(tumor necrosis factor-α,TNF-α)、白细胞介素-1β(interleukin-1β,IL-1β)水平;HE染色观察小鼠踝关节组织病理学情况;蛋白免疫印迹法(Western blot)检测小鼠踝关节组织中核因子κB(nuclear factor kappa-B,NF-κB)、蛋白激酶B(threonine protein kinase,AKT)、TNF-α、IL-1β蛋白表达水平。结果FBX组、LA组小鼠关节肿胀度均有不同程度的显著降低(P<0.05)。与MOD组比较,FBX组和LA组血清UA浓度、MDA、XOD、TNF-α、IL-1β水平降低(P<0.05),CAT、SOD水平显著升高(P<0.05)。HE染色结果显示,与CON组比较,MOD组小鼠关节炎性细胞浸润明显;与MOD组比较,FBX组和LA组炎性细胞浸润减轻,细胞形态相对光滑完整。Western blot结果显示,与MOD组比较,FBX组和LA组关节组织中NF-κB、AKT、TNF-α、IL-1β蛋白表达水平显著降低(P<0.05)。结论甘草附子汤对风寒湿痹型痛风性关节炎小鼠具有保护作用,其机制可能是通过改善模型小鼠体内氧化应激状态,抑制NF-κB/AKT信号通路激活,下调下游炎症因子TNF-α、IL-1β表达,达到减轻小鼠关节炎症的效果。

谈寒湿疫之寒湿入营

仝小林院士提出新型冠状病毒感染属寒湿疫,其病理因素为寒湿,应从散寒化湿而治。寒湿入营是寒湿疫特殊证型,见于危重阶段,其病因病机及辨治施治均不同于热入营分。从寒湿入营的特点及鉴别角度进一步梳理、更新、完善寒湿疫辨证理论体系,诠释寒湿入营理论的临床意义,以期为寒湿疫危重症防治提供新思路。